Biochemical effects of quipazine on rat striatal dopaminergic system.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000494:pharmacology; D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism / Q000502:physiology*; D004298:Dopamine / Q000502:physiology*; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D008297:Male; D008711:Metergoline / Q000494:pharmacology; D008781:Methyltyrosines / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D011814:Quipazine / Q000494:pharmacology*; D051381:Rats
D008781:Methyltyrosines; D011804:Quinolines; D015102:3,4-Dihydroxyphenylacetic Acid; D008711:Metergoline; D011814:Quipazine; D010293:Pargyline; D006220:Haloperidol; D004298:Dopamine; D006719:Homovanillic Acid